8-K: Verano Reports Q4 & FY25 Results, Secures $195M Loan

Verano Holdings Corp. announced its fourth quarter and full year 2025 financial results, alongside the closing of a new $195 million senior secured term loan with favorable terms.

Summary

• Fourth quarter 2025 revenues, net of discounts, were $207 million, an increase of 2% versus the prior quarter, but a decrease of 5% year-over-year.
• Full year 2025 revenues, net of discounts, were $822 million, a decrease of 6% year-over-year.
• Adjusted EBITDA for Q4 2025 was $56 million (27% of revenue), in line with guidance.
• Adjusted EBITDA for full year 2025 was $229 million (28% of revenue).
• Net loss for Q4 2025 was $(183) million and for full year 2025 was $(258) million.
• Closed a new $195 million senior secured term loan with an initial 9.5% annual interest rate and a maturity date of March 11, 2029.
• Drew the remaining $50 million under its existing revolving credit facility, which was upsized to $100 million and extended to February 28, 2029.
• Redomiciled the Company from British Columbia, Canada to the State of Nevada.
• Reached a comprehensive settlement to dismiss all outstanding litigation matters with Vireo Growth Inc.
• Awarded one of nine conditional licenses to commence vertical cannabis operations in Texas.
• Expanded retail footprint to 160 dispensaries nationwide across 13 states.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive report. While revenue declined year-over-year and net losses persist, the company achieved sequential improvements, met EBITDA guidance, and significantly strengthened its balance sheet through a favorable debt refinancing, positioning it well for future industry catalysts.

Positives

• Achieved sequential revenue and margin improvement within guidance in the fourth quarter of 2025.
• Adjusted EBITDA of $56 million in Q4 2025 was in line with company guidance.
• Secured a new $195 million senior secured term loan with favorable terms, including an initial 9.5% annual interest rate, March 11, 2029 maturity, and prepayment flexibility.
• Refinanced and retired all outstanding indebtedness under the prior October 2022 credit agreement, improving the capital structure.
• Upsized the revolving credit facility commitment to $100 million and extended its maturity date to February 28, 2029.
• Solidified top three market share positions across all competing categories for Verano brands in 2025.
• Successfully streamlined operations and generated efficiencies throughout 2025.
• Implemented CPG technology and automation upgrades and launched new product innovation and partnerships.
• Redomiciled the Company from Canada to Nevada, strategically positioning for potential U.S. capital markets inclusion.
• Reached a favorable settlement to the Vireo litigation, resolving outstanding legal matters.
• Won a conditional vertical license in Texas, anticipating medical program expansion in a key state.
• Net loss decreased year-over-year for both Q4 2025 (from $(273) million to $(183) million) and FY 2025 (from $(342) million to $(258) million), primarily driven by lower impairment charges.
• Capital expenditures for FY 2025 significantly decreased to $41 million from $99 million in FY 2024, indicating improved capital efficiency.

Negatives

• Full year 2025 revenues decreased by 6% year-over-year to $822 million.
• Fourth quarter 2025 revenues decreased by 5% year-over-year, primarily due to ongoing price compression and competition.
• Full year 2025 gross profit decreased to $413 million (50% of revenue) from $444 million (51% of revenue) in 2024.
• Reported a net loss of $(183) million for Q4 2025 and $(258) million for FY 2025.
• Adjusted EBITDA for FY 2025 decreased to $229 million from $264 million in FY 2024.
• Net cash provided by operating activities for Q4 2025 was $14 million, down from $44 million in Q4 2024, driven by inventory adjustments and higher income tax payments.
• Net cash provided by operating activities for FY 2025 was $53 million, down from $112 million in FY 2024.

Risks

• Forward-looking statements are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements to be materially different from those expressed or implied.
• Specific risk factors are described in the Company's annual report on Form 10-K for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission.

Future Outlook

Verano expects capital expenditures for 2026 to range between $30 million and $50 million, supporting cultivation efficiency, selective retail expansion, store enhancements, and technology investments. The company is strategically positioned to leverage potential catalysts in 2026, including an anticipated final rule for cannabis rescheduling and its operations in key states like Florida, Pennsylvania, Virginia, and Texas.

Management Comments

• "I am incredibly proud of our team for their resilience and tremendous efforts executing an exceptional game plan in 2025." George Archos, Verano founder, Chairman and Chief Executive Officer.
• "Throughout 2025, we successfully streamlined operations and generated efficiencies, implemented CPG technology and automation upgrades, and launched new product innovation and partnerships that solidified top three share positions for Verano brands in every category we compete in." George Archos, Verano founder, Chairman and Chief Executive Officer.
• "We also strategically positioned Verano ahead of potential U.S. capital markets inclusion by redomiciling the Company from Canada to Nevada, secured what we believe to be one of the industry’s most beneficial credit facilities, reached a favorable settlement to the Vireo litigation, and won a conditional vertical license in Texas as the state prepares for a medical program expansion." George Archos, Verano founder, Chairman and Chief Executive Officer.
• "As we await an anticipated final rule from the President’s executive order to expeditiously reschedule cannabis and as the only cannabis business with current or pending operations in Florida, Pennsylvania, Virginia, and Texas, we are well-positioned to leverage a number of potential catalysts in what may be a game-changing year for Verano and the industry in 2026." George Archos, Verano founder, Chairman and Chief Executive Officer.
• "Securing our new $195 million term loan backed by a highly respected regional institution in Needham Bank is a watershed moment for Verano, serving as powerful validation of our operational and financial discipline." George Archos, Verano Chief Executive Officer and President.
• "We believe this arrangement provides Verano some of the most beneficial terms in the industry including a significantly lower cost of capital, maturity date and prepayment flexibility, and favorable interest rates." George Archos, Verano Chief Executive Officer and President.
• "With our new facility now in place, we are well-positioned to continue strengthening our balance sheet, and executing strategic growth initiatives aimed at generating long-term value for the Company, our employees and shareholders." George Archos, Verano Chief Executive Officer and President.
• "In addition to our role as Administrative Agent, Needham Bank is pleased to offer a comprehensive suite of financial services including credit, state-of-the-art cash management and consumer payments to Verano, a premier cannabis operator." Joseph Campanelli, Chairman, President & CEO of Needham Bank.
• "Our ability to provide local decision making and a compliant, nationwide banking platform perfectly aligns with Verano’s operational excellence and strong financial profile." Joseph Campanelli, Chairman, President & CEO of Needham Bank.
• "We are thrilled to build upon our relationship with Verano through a partnership of bank and non-bank capital. Needham and Chicago Atlantic operate on the forefront of bringing mainstream financial products to the US cannabis industry." Peter Sack, Managing Partner of Chicago Atlantic.

Industry Context

StockSavvy.ai notes that Verano's ability to secure a $195 million senior secured term loan from a regional bank like Needham Bank, with an initial 9.5% interest rate, is a significant development in the cannabis industry. This demonstrates a growing willingness of traditional financial institutions to engage with the sector, potentially signaling a broader trend towards lower-cost capital access for established MSOs. The strategic redomiciling to Nevada also positions Verano to capitalize on potential federal cannabis reforms, aligning with industry expectations for future U.S. capital markets inclusion. The company's focus on operational efficiencies and market share in key states like Florida, Pennsylvania, Virginia, and Texas reflects a common strategy among leading MSOs to consolidate and prepare for potential federal rescheduling.

Comparison to Industry Standards

• Verano's new $195 million term loan at an initial 9.5% annual interest rate is described by management as 'among the industry’s most favorable terms.' This rate is competitive within the cannabis sector, where financing costs have historically been significantly higher due to federal illegality. For instance, some cannabis companies have faced interest rates well into the double digits (e.g., 12-15% or higher) on similar secured debt facilities from non-bank lenders.
• The involvement of Needham Bank, a Massachusetts commercial bank, as administrative agent, further distinguishes this financing, as traditional banks have largely shied away from direct lending to cannabis companies. This suggests Verano has achieved a financing structure that is more aligned with conventional corporate lending, albeit still reflecting the inherent risks of the cannabis industry compared to non-cannabis sectors where similar-sized companies might secure rates in the 5-8% range.

Corporate Governance

Legal Proceedings

• Reached a comprehensive settlement to dismiss all outstanding litigation matters between the Company and Vireo Growth Inc.

Stakeholder Impact

• Shareholders: Potential for long-term value generation through strategic growth initiatives, improved capital structure, and positioning for federal cannabis reforms. Continued net losses and revenue decline may concern some.
• Creditors: New credit facility provides a more stable and favorable debt structure, reducing risk for new lenders and potentially improving creditworthiness.
• Employees: Continued operational streamlining and efficiency efforts may impact workforce, but strategic growth initiatives could create new opportunities.
• Customers: New product launches, brand partnerships, and retail expansion aim to enhance product availability and shopping experience.

Next Steps

• Anticipated final rule from the President's executive order to expeditiously reschedule cannabis.
• Continued support of cultivation operational efficiency.
• Selective expansion of retail operations in existing and potential new markets.
• Retail store enhancements.
• Continued investment in technology and infrastructure.
• Monthly principal repayments of $875,000 for the term loan beginning in April 2026.
• Conference call and webcast with analysts and investors on March 12, 2026, at 8:30 a.m. ET / 7:30 a.m. CT.

Key Dates

Recommendation

While Verano demonstrated sequential improvements and secured a highly favorable debt refinancing, the year-over-year revenue decline and persistent net losses indicate ongoing challenges in the competitive cannabis market. The strategic moves, such as redomiciling and the Texas license, position the company well for future industry catalysts, but the immediate financial performance suggests a 'hold' until clearer signs of sustained revenue growth and profitability emerge from the current market pressures and potential regulatory changes.

Keywords

Cannabis, Multi-state operator, MSO, Verano Holdings, VRNO, Financial Results, Earnings, Credit Facility, Debt Refinancing, Adjusted EBITDA, Revenue, Net Loss, Capital Expenditures, Cannabis Industry, SEC Filing, Form 8-K, Zen Leaf, MV Dispensary, Nevada Redomicile, Texas License, Vireo Litigation, Needham Bank, Chicago Atlantic